Jacob Rachmilewitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jacob Rachmilewitz has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Zipora Borovsky
From the Goldyne Savad Institute of Gene Therapy; Department of Orthopedic Surgery; The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine; and the Skeletal Biotechnology Laboratory, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
5 shared publicationsGalit Mishan-Eisenberg
Goldyne Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel
3 shared publicationsEinat Yaniv
Goldyne Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel
2 shared publicationsMark L. Tykocinski
Department of Pathology and Laboratory Medicine, University of Pennsylvania , Philadelphia, PA 19104
2 shared publicationsAntonio Lanzavecchia
1 shared publicationDror Mevorach
From the Goldyne Savad Institute of Gene Therapy; Department of Orthopedic Surgery; The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine; and the Skeletal Biotechnology Laboratory, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
1 shared publication
Latest Publications
- 31 December 2007
- Published by Springer Nature
- Vol. 640, 95-102
Serial Triggering Model
T-cells recognize a foreign antigen when presented on antigen-presenting cells (APCs) in the context of a peptide bound to major histocompatibility complex (MHC). Ihe recognition of an antigen takes place at the T-cell: APC contact site where an “immune synapse” is formed and the multichain T-cell antigen receptor (TCR) is triggered. This initiates a signal transduction cascade that involves activation of tyrosine kinases, which in turn activate downstream events that elicit a diverse array of effector functions. T-cell activation requires a sustained signal that lasts for several hours. However, TCR affinity to its antigen is low and activation of TCR induces only a brief spike of intracellular signals. The serial triggering model resolves these seemingly paradoxical requirements for T-cell activation. The model states that sustained signaling is accomplished by the concerted action of multiple T-cell receptors that are sequentially engaged with and triggered by the peptide:MHC complex. In this chapter, we review the serial triggering model and two other models that expand this model. These models describe kinetic aspects of T-cell activation such as the pivotal question of how the T-cell “counts” the number of serially triggered receptors over time and how it determines that a threshold level has been reached for the activation of T-cell response.
- 31 December 2007
- Published by Springer Nature
- Vol. 640, 95-102
Serial Triggering Model
T-cells recognize a foreign antigen when presented on antigen-presenting cells (APCs) in the context of a peptide bound to major histocompatibility complex (MHC). Ihe recognition of an antigen takes place at the T-cell: APC contact site where an “immune synapse” is formed and the multichain T-cell antigen receptor (TCR) is triggered. This initiates a signal transduction cascade that involves activation of tyrosine kinases, which in turn activate downstream events that elicit a diverse array of effector functions. T-cell activation requires a sustained signal that lasts for several hours. However, TCR affinity to its antigen is low and activation of TCR induces only a brief spike of intracellular signals. The serial triggering model resolves these seemingly paradoxical requirements for T-cell activation. The model states that sustained signaling is accomplished by the concerted action of multiple T-cell receptors that are sequentially engaged with and triggered by the peptide:MHC complex. In this chapter, we review the serial triggering model and two other models that expand this model. These models describe kinetic aspects of T-cell activation such as the pivotal question of how the T-cell “counts” the number of serially triggered receptors over time and how it determines that a threshold level has been reached for the activation of T-cell response.
- Top Cited PapersOpen Access
- 1 March 2005
- Published by American Society of Hematology in Blood
- Vol. 105 (5) , 2214-2219
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
Infusion of either embryonic or mesenchymal stem cells prolongs the survival of organ transplants derived from stem cell donors and prevents graft-versus-host-disease (GVHD). An in-depth mechanistic understanding of this tolerization phenomenon could lead to novel cell-based therapies for transplantation. Here we demonstrate that while human mesenchymal stem cells (hMSCs) can promote superantigen-induced activation of purified T cells, addition of antigen-presenting cells (APCs; either monocytes or dendritic cells) to the cultures inhibits the T-cell responses. This contact- and dose-dependent inhibition is accompanied by secretion of large quantities of interleukin (IL)–10 and aberrant APC maturation, which can be partially overridden by the addition of factors that promote APC maturation (ie, lipopolysaccharide [LPS] or anti-CD40 monoclonal antibody [mAb]). Thus, our data support an immunoregulatory mechanism wherein hMSCs inhibit T cells indirectly by contact-dependent induction of regulatory APCs with T-cell–suppressive properties. Our data may reveal a physiologic phenomenon whereby the development of a distinct APC population is regulated by the tissue's cellular microenvironment.
- 1 March 2005
- Published by American Society of Hematology in Blood
- Vol. 105 (5) , 2214-2219
Top Cited PapersOpen AccessHuman mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
Infusion of either embryonic or mesenchymal stem cells prolongs the survival of organ transplants derived from stem cell donors and prevents graft-versus-host-disease (GVHD). An in-depth mechanistic understanding of this tolerization phenomenon could lead to novel cell-based therapies for transplantation. Here we demonstrate that while human mesenchymal stem cells (hMSCs) can promote superantigen-induced activation of purified T cells, addition of antigen-presenting cells (APCs; either monocytes or dendritic cells) to the cultures inhibits the T-cell responses. This contact- and dose-dependent inhibition is accompanied by secretion of large quantities of interleukin (IL)–10 and aberrant APC maturation, which can be partially overridden by the addition of factors that promote APC maturation (ie, lipopolysaccharide [LPS] or anti-CD40 monoclonal antibody [mAb]). Thus, our data support an immunoregulatory mechanism wherein hMSCs inhibit T cells indirectly by contact-dependent induction of regulatory APCs with T-cell–suppressive properties. Our data may reveal a physiologic phenomenon whereby the development of a distinct APC population is regulated by the tissue's cellular microenvironment.
- Open Access
- 1 November 2004
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 173 (9) , 5524-5530
Differential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 14
The potency of TCR signaling during primary CD4+ T cell activation influences initial cytokine expression patterns and subsequent polarization toward either Th1 or Th2 subsets. In this study, we demonstrate that the T cell inhibitor placental protein 14 (PP14; glycodelin) preferentially inhibits Th1 cytokine responses and chemokine expression when present during ex vivo priming of CD4+ T cells. PP14 synergizes with exogenously added IL-4 in skewing T cell responses. Significantly, PP14 impairs the down-regulation of GATA-3 transcriptional regulator expression that normally accompanies T cell activation, which is a prerequisite for Th1 development. Taken together, these data document for the first time the ability of PP14 to skew Th responses.
- 1 November 2004
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 173 (9) , 5524-5530
Open AccessDifferential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 14
The potency of TCR signaling during primary CD4+ T cell activation influences initial cytokine expression patterns and subsequent polarization toward either Th1 or Th2 subsets. In this study, we demonstrate that the T cell inhibitor placental protein 14 (PP14; glycodelin) preferentially inhibits Th1 cytokine responses and chemokine expression when present during ex vivo priming of CD4+ T cells. PP14 synergizes with exogenously added IL-4 in skewing T cell responses. Significantly, PP14 impairs the down-regulation of GATA-3 transcriptional regulator expression that normally accompanies T cell activation, which is a prerequisite for Th1 development. Taken together, these data document for the first time the ability of PP14 to skew Th responses.
- 1 April 2003
- Published by Elsevier in Cellular Immunology
- Vol. 222 (2) , 156-163
Placental protein 14 regulates selective B cell responses
- 1 April 2003
- Published by Elsevier in Cellular Immunology
- Vol. 222 (2) , 156-163
Placental protein 14 regulates selective B cell responses
- Open Access
- 1 April 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (16) , 14059-14065
Negative Regulation of T Cell Activation by Placental Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor CD45
- 1 April 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (16) , 14059-14065
Open AccessNegative Regulation of T Cell Activation by Placental Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor CD45
- 1 December 2002
- Published by Elsevier in Trends in Immunology
- Vol. 23 (12) , 592-595
A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding
- 1 December 2002
- Published by Elsevier in Trends in Immunology
- Vol. 23 (12) , 592-595
A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding
- Open Access
- 1 June 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (24) , 21529-21536
Serial Triggering of T Cell Receptors Results in Incremental Accumulation of Signaling Intermediates
- 1 June 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (24) , 21529-21536
Open AccessSerial Triggering of T Cell Receptors Results in Incremental Accumulation of Signaling Intermediates